Merck KGaA Says Third-Quarter Profit Rises 7.5%, Beating Analyst Estimates
Merck KGaA , the German maker of cancer drug Erbitux, reported third-quarter profit that beat analysts' estimates because of growth at the Merck Serono pharmaceutical and Millipore equipment businesses.
Join the discussion below, or Read more at Bloomberg.
#1 Nov 1, 2011
Add your comments below
|Kitchen For Sale In Glasgow Area UK||Oct '16||Anonymous||1|
|OSI Systems's Sell Rating Reaffirmed at Benchma... (Dec '13)||Jan '16||Human||35|
|Microvision, Inc. (MVIS) Coverage Initiated at ... (Dec '15)||Dec '15||emanresu||1|
|Simisometer (Jan '13)||Aug '15||DC from LA||2|
|EARTHQUAKES: University of Oklahoma developed q... (Jun '15)||Jun '15||great||1|
|3D Systems: Weighing The Bankruptcy Risk (Mar '15)||May '15||SuriJohn||2|
|Oil tycoon Harold Hamm reportedly tried to get ... (May '15)||May '15||bizness is biznes...||1|
Find what you want!
Search Scientific Instruments Forum Now
Copyright © 2016 Topix LLC